C.G. Pihl

CHARACTERISTICS OF SCREENING DETECTED PROSTATE CANCER IN MEN 50 TO 66 YEARS OLD WITH 3 TO 4 NG./ML. PROSTATE SPECIFIC ANTIGEN

P. Lodding, Gunnar Aus, Svante Bergdahl et al. · The Journal of Urology · 1998 · 141 citations

Medicine, Oncology, Urology +17

Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC)

Theodorus van der Kwast, Lukas Bubendorf, Catherine Mazerolles et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2013 · 61 citations

Medicine, Pathology, Urology +17

Population‐based screening for prostate cancer by measuring free and total serum prostate‐specific antigen in Sweden

Jonas Hugosson, Gunnar Aus, Svante Bergdahl et al. · British Journal of Urology · 2003 · 48 citations

Medicine, Oncology, Urology +17

Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer

Marita Laurila, Theodorus van der Kwast, Lukas Bubendorf et al. · European Journal of Cancer · 2010 · 29 citations

Medicine, Oncology, Urology +16

Report of the Pathology Committee: false‐positive and false‐negative diagnoses of prostate cancer

Theodorus van der Kwast, Carlos Lopes, Petri Martikainen et al. · British Journal of Urology · 2003 · 21 citations

Medicine, Pathology, Urology +16